Publications by authors named "Susan E Stuber"

Claim this Profile
H
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations.
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, George Mochamah, Peter Olupot-Olupot, Susan E Stuber

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial.
Rosa M Nieves, Teresa Latham, Nicolle Marte, Melissa Berges, Luisanna M Sánchez, Susan E Stuber

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial.
Alexandra Power-Hays, Ruth Namazzi, Charles Kato, Kathryn E McElhinney, Andrea L Conroy, Susan E Stuber

Acta Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea for Children and Adults with Hemoglobin SC Disease.
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, Adam C Lane, Klenam Dzefi-Tettey, Susan E Stuber

NEJM Evid· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.
Catherine I Segbefia, Luke R Smart, Susan E Stuber, Kwesi N Amissah-Arthur, Klenam Dzefi-Tettey

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Banu Aygun, Adam Lane, Luke R Smart, Brígida Santos, Léon Tshilolo, Susan E Stuber

Lancet Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.
Alexandra Power-Hays, George A Tomlinson, Leon Tshilolo, Brígida Santos, Thomas N Williams, Susan E Stuber

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease.
Luke R Smart, Catherine I Segbefia, Teresa S Latham, Susan E Stuber, Kwesi N Amissah-Arthur

Trials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.
Emmanuela E Ambrose, Teresa S Latham, Primrose Songoro, Mwesige Charles, Adam C Lane, Susan E Stuber

Lancet Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.
Luke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, Primrose Songoro, Idd Shabani, Susan E Stuber

Acta Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
Peter Olupot-Olupot, George Tomlinson, Thomas N Williams, Léon Tshilolo, Brígida Santos, Susan E Stuber

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
Léon Tshilolo, George Tomlinson, Thomas N Williams, Brígida Santos, Peter Olupot-Olupot, Susan E Stuber

N Engl J Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia.
Neelum D Jeste, Luisanna M Sánchez, Gabriela S Urcuyo, Melissa E Bergés, Judy P Luden, Susan E Stuber

JMIR Res Protoc· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.
Angela E Rankine-Mullings, Courtney R Little, Marvin E Reid, Deanne P Soares, Carolyn Taylor-Bryan, Susan E Stuber

JMIR Res Protoc· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Russell E Ware, Barry R Davis, William H Schultz, R Clark Brown, Banu Aygun, Susan E Stuber

Lancet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis